Close
Direct-to-patient (DTP) services are reshaping clinical trials by bringing investigational products and study procedures directly to patients, improving accessibility and engagement. Intrigence enhances DTP operations through AI-enabled logistics management, patient communication, and compliance tracking, ensuring seamless and patient-centric trial experiences.
Especially post-pandemic, decentralized clinical trials with DTP models have gained traction. However, managing product shipment, adherence monitoring, and remote site coordination presents unique challenges, including complex supply chain demands and ensuring regulatory compliance across diverse geographies.
Intrigence leverages AI-powered route optimization and predictive analytics to manage the delivery of investigational products efficiently. Real-time tracking ensures timely shipments and minimizes cold chain breaches.
Our platform uses AI chatbots and automated alerts to maintain continuous patient engagement, improving adherence and retention. Advanced data analytics monitor patient-reported outcomes and medication compliance remotely, flagging risks early.
AI optimizes shipment routes and manages logistics dynamically.
Automated, personalized communications keep patients informed and engaged.
Continuous monitoring ensures adherence to storage and handling protocols.
Real-time insights allow rapid intervention for patient support.
Our AI platform integrates with wearable devices and patient apps, creating a connected ecosystem for decentralized trials. Intrigence’s adaptable modules allow sponsors to customize DTP workflows according to protocol needs, enhancing flexibility and control.
